000661.SZ Overview

Company Profile

Related stocks

600079.SS • China

HUMANWELL HEALTHCARE (GROUP) CO

19.23 CNY

4.7B USD 1Y -10.1%

000739.SZ • China

APELOA PHARMA.

25.4 CNY

4.4B USD 1Y +55.9%

002603.SZ • China

YILING

15.53 CNY

3.88B USD 1Y -4.1%

600329.SS • China

TIANJIN PHARMACEUTICAL DA REN T

35.8 CNY

4.13B USD 1Y -17.6%

600521.SS • China

ZHEJIANG HUAHAI PHARMACEUTICAL

17.45 CNY

3.91B USD 1Y -16.9%

2196.HK • China

FOSUN PHARMA

17.87 HKD

6.08B USD 1Y -29.9%

000513.SZ • China

LIVZON GROUP

30.5 CNY

4.05B USD 1Y -21.4%

000963.SZ • China

HD MEDICINE

27.29 CNY

7.16B USD 1Y -34.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

China

Region

Asia-Pacific

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

40.4% p.a.

Max Drawdown (5Y)

-79.9%

Sharpe Ratio (5Y)

-0.67

Beta Factor

0.34

Size Class

Large Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (40.4% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -87.9% in the extended horizon.